FFA
MNPR icon

Farther Finance Advisors’s Monopar Therapeutics MNPR Stock Holding History

Farther Finance Advisors’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22K Buy
+24
New +$1.49K ﹤0.01% 5136

Other funds holding MNPR

MIM
Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's MNPR Position: Q2 2026 in Review

Farther Finance Advisors opened a new position in Monopar Therapeutics (MNPR) in Q2 2026: 24 shares worth $2.22K. The stake represents ﹤0.01% of the portfolio and ranks #5136 among its holdings.

3 funds tracked by Wall St. Rank hold MNPR as of Q2 2026.

  • Farther Finance Advisors held 24 shares of Monopar Therapeutics worth $2.22K as of Q2 2026.
  • Monopar Therapeutics was a new Farther Finance Advisors position in Q2 2026.
  • Monopar Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5136 holding.
  • 3 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.